Straumann has received a US patent for a bioactive coating for their implants. Their modified sandblasted and acid-etched (SLA) surface is coated with an Arg–Gly–Asp (RGD)-peptide-modified polymer (PLL-g-PEG/PEG–RGD). According to a study by Danny Buser, RGD-coated implants demonstrated significantly higher percentages of bone-to-implant contact as compared with controls at 2 weeks. The hypothesized mechanism is that the attachment of RGD peptides directed towards integrin receptors on the PEGylated surface promotes adhesion of cells of mesenchymal origin e.g. osteoblasts to the implant surface.

More

<<< Back      E-Mail This     Topic: Implant Surface